ad image

Company Info

Servier

Servier

CDMO

Overview

Servier is a global pharmaceutical company that brings 60 years of expertise to its embedded CDMO business. As a full-service CDMO with large pharmaceutical roots, Servier has the knowledge, experience and quality track record to take your molecule from concept to approval. With 11 global facilities and a presence in 48 countries, Servier CDMO manufactures 27 billion units per year and has launched more than 50 commercial products to date. Our integrated services include development, manufacturing, packaging and supply chain support for drug substance and drug product. Servier CDMO represents embedded protection for your molecule.
Servier
Contributions
30 Contributions1 / 2
What’s Next for the Supply Chain Post-Pandemic
COVID-19

What’s Next for the Supply Chain Post-Pandemic

Gwenaël Servant, Ph.D.

Servier

PAP-Q2-20-CL-033Jul 01, 2020
Servier

Servier Acquires Symphogen

Servier

PR-M04-20-NI-006Apr 03, 2020
CDMO Services Designed to Support Evolving Pharma Business Models
Business Models

CDMO Services Designed to Support Evolving Pharma Business Models

Patrice Martin

Servier

PAP-Q1-20-CL-007Mar 19, 2020
Servier
Collaboration

Cellectis and Servier Execute the Amendment Confirming the Expansion of Their Collaboration on UCART19 Products

Servier

PR-M03-20-NI-008Mar 05, 2020
Giving Structure to a Long-Term CSR Strategy
Corporate Social Responsibility

Giving Structure to a Long-Term CSR Strategy

Vincent Minvielle

Servier

PAP-Q4-19-CL-030Dec 06, 2019
Meeting the Need for Higher Containment
Containment

Meeting the Need for Higher Containment

Suzanne Greene

Servier

PAP-Q3-19-CL-025Oct 28, 2019
Revisiting the Global Serialization Landscape
Serialization Update

Revisiting the Global Serialization Landscape

Michael Kinsella

Servier

PAP-Q2-2019-CL-030May 24, 2019
Servier
Expansion

Servier Cuts Ribbon on New Boston Headquarters

Servier

PR-M05-19-NI-037May 13, 2019
Aligning the Outsourcing Relationship
Outsourcing

Aligning the Outsourcing Relationship

Servier

PAP-Q1-2019-CL-006Apr 12, 2019
Risk Minimization with an Integrated Global Network
Global Network

Risk Minimization with an Integrated Global Network

Servier

PAP-Q4-18-CL-005Oct 26, 2018
Accelerating Time to Market with Integrated Preparative Chromatography Support
Chromatography

Accelerating Time to Market with Integrated Preparative Chromatography Support

Christophe Berini

Servier

PAP-Q3-18-CL-010Oct 02, 2018
Reducing Time to Market with Targeted Regulatory Affairs Support
Regulatory

Reducing Time to Market with Targeted Regulatory Affairs Support

Maryse Phan

Servier

PAO-06-18-CL-003Jun 20, 2018
Corporate Social Responsibility as a Driver for Improved Sustainability
Corporate Social Responsibility

Corporate Social Responsibility as a Driver for Improved Sustainability

Allain de Wilde; Loïc Allanos

Servier

PAP-Q2-18-CL-014May 29, 2018
Servier
Endpoint

Phase III Study Evaluating the Efficacy and Safety of Lonsurf in Patients with Metastatic Gastric Cancer Meets Primary Endpoint

Servier

PR-M05-18-NI-040May 10, 2018
Servier
Acquisition

Shire Announces Sale of Oncology Business to Servier for $2.4 Billion

Servier

PR-M04-18-NI-59Apr 16, 2018
Transforming A CDMO Using an Operational Excellence Approach
Operational Excellence

Transforming A CDMO Using an Operational Excellence Approach

Sébastien Mathieu; Laurent Dray

Servier

PAO-M03-18-CL-003Mar 29, 2018
Servier
Innovation

WeHealth by Servier and DEEPLINK MEDICAL sign a partnership to develop a new e-health solution

Servier

PR-M03-18-NI-059Mar 16, 2018
Why Business Continuity Management is Important for CDMOs
Industry

Why Business Continuity Management is Important for CDMOs

Mayeul Cauvin

Servier

PAP-Q1-18-CL-003Mar 12, 2018
Servier
Strategic Partnership

ImmunoQure AG and Servier Enter into Strategic Partnership for the Development of an Interferon-alpha Human Autoantibody

Servier

PR-M02-18-NI-64-4706Feb 14, 2018
Servier
Partnership

Servier Canada and the New Brunswick Health Research Foundation announce the creation of the Servier-New Brunswick Cardiac Health Improvement Fund (CHIF)

Servier

PR-M01-18-NI-058Jan 19, 2018
1 / 2